Rubicon Genomics Signs Supply Agreement with Agilent Technologies for PicoPLEX WGA Kit


Ann Arbor-based Rubicon Genomics, Inc. — a leading provider of pre-analytical library preparation kits that increase the accuracy, efficiency, and speed of genomic analysis — announced today that it has signed a supply agreement with Agilent Technologies for its PicoPLEX Whole Genome Amplification kits.

PicoPLEX WGA kits amplify DNA to yield a highly reproducible library from a single cell and will be sold with Agilent’s GenetiSure Pre-Screen Kit and used for comprehensive genome-wide analysis of day 5 embryos, including aneuploidy analysis of all 24 chromosomes.

“Our patented PicoPLEX WGA kits have a well-earned reputation for quality and reproducibility in the assisted reproduction field, where they have been a key component in pre-implantation genetic screening,” says James Koziarz, PhD, chief executive officer of Rubicon. “We’re delighted that Agilent will be making our kits available to their customers, joining a growing list of leading technology companies who offer our PicoPLEX technology.”

Rubicon’s PicoPLEX kits’ single tube protocol eliminates handling errors, dramatically improves time to results and reduces background. PicoPLEX WGA technology can also be applied to genetic characterization of any single cell sample or picogram quantities of isolated DNA. The kits are appropriate for use in microarray analyses as well as in PCR assays. PicoPLEX WGA kits are for research use only.

Facebook Comments